newsfilter
← Latest News
Business Wire·

Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results

– First Quarter 2023 Total Revenue of $33.4 Million; Net Product Revenue for QINLOCK® Increased 15% to $33.2 Million Compared to First Quarter 2022 – – Enrollment Complete in the MOTION Pivotal Phase 3 Study of